DECEMBER 2022 PUBLICATIONS

Cancer Control & Population Sciences

Cancer Therapeutics & Host Response

Mechanisms of Oncogenesis


Cancer Control & Population Sciences

Braithwaite D, Gould MK. Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit? JAMA Netw Open. 2022 Nov 1;5(11):e2243171. doi: 10.1001/jamanetworkopen.2022.43171. No abstract available. PubMed PMID: 36409500.

Salloum RG, LeLaurin JH, Nakkash R, Akl EA, Parascandola M, Ricciardone MD, Elbejjani M, Kabakian-Khasholian T, Lee JH, El-Jardali F, Shelley D, Vinson C. Developing Capacity in Dissemination and Implementation Research in the Eastern Mediterranean Region: Evaluation of a Training Workshop. Glob Implement Res Appl. 2022 Nov 14:1-10. doi: 10.1007/s43477-022-00067-y. Online ahead of print. PubMed PMID: 36407476; PubMed Central PMCID: PMC9660112.

Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, Ginsburg O, Mailhot Vega RB, Galukande M, Parham G, Vaccarella S, Canfell K, Ilbawi AM, Anderson BO, Bray F, Dos-Santos-Silva I, McCormack V. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022 Nov 20. doi: 10.1038/s41591-022-02109-2. Online ahead of print. PubMed PMID: 36404355.

Fielding RA, Atkinson EJ, Aversa Z, White TA, Heeren AA, Achenbach SJ, Mielke MM, Cummings SR, Pahor M, Leeuwenburgh C, LeBrasseur NK. Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study. Geroscience. 2022 Nov 11. doi: 10.1007/s11357-022-00685-2. Online ahead of print. PubMed PMID: 36367600.

Austin-Datta RJ, Chaudhari PV, Cheng TD, Klarenberg G, Striley CW, Cottler LB. Electronic Nicotine Delivery Systems (ENDS) use Among Members of a Community Engagement Program. J Community Health. 2022 Nov 27:1-9. doi: 10.1007/s10900-022-01169-2. Online ahead of print. PubMed PMID: 36436165; PubMed Central PMCID: PMC9702843.

Hathaway CA, Wang T, Townsend MK, Vinci C, Jake-Schoffman DE, Saeed-Vafa D, Moran Segura C, Nguyen JV, Conejo-Garcia JR, Fridley BL, Tworoger SS. Lifetime Exposure to Cigarette Smoke and Risk of Ovarian Cancer by T Cell Tumor Immune Infiltration. Cancer Epidemiol Biomarkers Prev. 2022 Nov 1:EPI-22-0877. doi: 10.1158/1055-9965.EPI-22-0877. Online ahead of print. PubMed PMID: 36318652.

Ramnaraign BH, Lee JH, Ali A, Rogers SC, Fabregas JC, Thomas RM, Allegra CJ, Sahin I, DeRemer DL, George TJ, Chatzkel JA. Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial. Future Oncol. 2022 Nov 18. doi: 10.2217/fon-2022-0392. Online ahead of print. PubMed PMID: 36399037.

Phillips AE, Tang G, Wang X, Forsmark CE, Yadav D. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis. Dig Dis Sci. 2022 Nov 12. doi: 10.1007/s10620-022-07750-y. Online ahead of print. PubMed PMID: 36370243.

Newsome FA, Cardel MI, Chi X, Lee AM, Miller D, Menon S, Janicke DM, Gurka MJ, Butryn ML, Manasse S. Wellness Achieved through Changing Habits: A Randomized Controlled Trial of an Acceptance-Based Intervention for Adolescent Girls with Overweight or Obesity. Child Obes. 2022 Nov 17. doi: 10.1089/chi.2022.0116. Online ahead of print. PubMed PMID: 36394498.

Nguyen OT, Turner K, Parekh A, Alishahi Tabriz A, Hanna K, Merlo LJ, Hong YR. Merit-based incentive payment system participation and after-hours documentation among US office-based physicians: Findings from the 2021 National Electronic Health Records Survey. J Eval Clin Pract. 2022 Nov 22. doi: 10.1111/jep.13796. Online ahead of print. PubMed PMID: 36416004.

Hong S, Zhao J, Wang S, Wang H, Lee JH, Farhadfar N, McGuirk JP, Savani BN, Shahrukh HK, Stiff P, Khera N, Hahn T, Loren AW, Jaglowski SM, Wood WA, Saber W, Cerny J, Holtan SG, Reynolds JM, Deol A, Jim H, Uberti J, Whalen V, Yi JC, Preussler J, Baker KS, Shaw BE, Devine S, Syrjala K, Majhail NS, Wingard JR, Al-Mansour Z. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplant (HCT) Survivors. Transplant Cell Ther. 2022 Nov 22:S2666-6367(22)01781-X. doi: 10.1016/j.jtct.2022.11.016. Online ahead of print. PubMed PMID: 36427784.

Marsolo K, Kiernan D, Toh S, Phua J, Louzao D, Haynes K, Weiner M, Angulo F, Bailey C, Bian J, Fort D, Grannis S, Krishnamurthy AK, Nair V, Rivera P, Silverstein J, Zirkle M, Carton T. Assessing the impact of privacy-preserving record linkage on record overlap and patient demographic and clinical characteristics in PCORnet(R), the National Patient-Centered Clinical Research Network. J Am Med Inform Assoc. 2022 Nov 30:ocac229. doi: 10.1093/jamia/ocac229. Online ahead of print. PubMed PMID: 36451264.

Kreher MA, Noland MMB, Konda S, Longo MI, Valdes-Rodriguez R. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids. J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03145-0. doi: 10.1016/j.jaad.2022.11.044. Online ahead of print. PubMed PMID: 36460257.

Kreher MA, Konda S, Noland MMB, Longo MI, Valdes-Rodriguez R. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors. J Am Acad Dermatol. 2022 Nov 29:S0190-9622(22)03146-2. doi: 10.1016/j.jaad.2022.11.043. Online ahead of print. PubMed PMID: 36460256.

Yang Y, Lindblom EN, Ward KD, Salloum RG. Should menthol e-cigarettes be banned? Reaction of adult smokers and users of e-cigarettes to hypothetical bans. Tob Control. 2022 Nov 29:tobaccocontrol-2022-057439. doi: 10.1136/tc-2022-057439. Online ahead of print. PubMed PMID: 36446577.

Osegueda ER, Chi X, Hall JM, Vadaparampil ST, Christy SM, Staras SAS. County-Level Factors Associated With HPV Vaccine Coverage Among 11-Year-Olds to 12-Year-Olds Living in Florida in 2019. J Adolesc Health. 2022 Oct 13. pii: S1054-139X(22)00625-5. doi: 10.1016/j.jadohealth.2022.09.005. [Epub ahead of print] PubMed PMID: 36244897.

Scarton L, Jo A, Xie Z, O’Neal LJ, Munoz Pena JM, George TJ, Bian J. Examining the relationship between metformin dose and cancer survival: A SEER-Medicare analysis. PLoS One. 2022 Oct 19;17(10):e0275681. doi: 10.1371/journal.pone.0275681. eCollection 2022. PubMed PMID: 36260549; PubMed Central PMCID: PMC9581409.

Patel CG, Peterson J, Aznar M, Tseng YD, Lester S, Pafundi D, Flampouri S, Mohindra P, Parikh RR, Mailhot Vega R, Konig L, Plastaras JP, Bates JE, Loap P, Kirova YM, Orlandi E, Lütgendorf-Caucig C, Ntentas G, Hoppe B. Systematic Review for Deep Inspiration Breath Hold in Proton Therapy for Mediastinal Lymphoma: A PTCOG Lymphoma Subcommittee Report and Recommendations. Radiother Oncol. 2022 Oct 14. pii: S0167-8140(22)04497-8. doi: 10.1016/j.radonc.2022.10.003. [Epub ahead of print] Review. PubMed PMID: 36252635.

Kim H, Mahmood A, Hammarlund NE, Chang CF. Hospital value-based payment programs and disparity in the United States: A review of current evidence and future perspectives. Front Public Health. 2022 Oct 10;10:882715. doi: 10.3389/fpubh.2022.882715. eCollection 2022. Review. PubMed PMID: 36299751; PubMed Central PMCID: PMC9589294.

Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection. Sci Rep. 2022 Oct 27;12(1):18094. doi: 10.1038/s41598-022-22819-4. PubMed PMID: 36302828; PubMed Central PMCID: PMC9613877.

Hochhegger B, Patel PP, Zanon M, Müller E, Ferreira Correa L, Verma N, Mohammed TL, Quinto Dos Reis Hochhegger D, Irion K, Marchiori E. Narrowing the Differential Diagnosis of Cystic Lesions in Smokers with Expiratory CT Acquisition Using the Cyst-Airway Communication Hypothesis. Lung. 2022 Oct 22. doi: 10.1007/s00408-022-00576-5. [Epub ahead of print] PubMed PMID: 36271930.

Alpert JM, Hampton CN, Raisa A, Markham MJ, Bylund CL. Integrating patient-centeredness into online patient-clinician communication: a qualitative analysis of clinicians’ secure messaging usage. Support Care Cancer. 2022 Oct 19. doi: 10.1007/s00520-022-07408-5. [Epub ahead of print] PubMed PMID: 36260178; PubMed Central PMCID: PMC9580446.

Griffin KT, Eckerman KF, Manger RP, Jokisch DW, Bolch WE, Hertel NE. Specific Absorbed Fractions for Spontaneous Fission Neutron Emitters in the ICRP Reference Pediatric Voxel Phantom Series. Health Phys. 2022 Oct 1;123(4):278-286. doi: 10.1097/HP.0000000000001594. Epub 2022 Jul 15. PubMed PMID: 35776943; PubMed Central PMCID: PMC9444919.

Golden SE, Schweiger L, Melzer AC, Ono SS, Datta S, Davis JM, Slatore CG. “It’s a decision I have to make”: Patient perspectives on smoking and cessation after lung cancer screening decisions. Prev Med Rep. 2022 Oct 5;30:102014. doi: 10.1016/j.pmedr.2022.102014. eCollection 2022 Dec. PubMed PMID: 36237837; PubMed Central PMCID: PMC9551209.

Kucharczyk MJ, Bang A, Tjong MC, Papatheodorou S, Fabregas JC. Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis. Oncotarget. 2022 Oct 8;13:1109-1119. doi: 10.18632/oncotarget.28280. PubMed PMID: 36251013; PubMed Central PMCID: PMC9564357.

Aduse-Poku L, Gopireddy DR, Hernandez M, Lall C, Divaker J, Falzarano SM, Masood S, Datta S, Zhang W, Jo A, Bian J, Cheng TD. Intraindividual Reliability of Opportunistic Computed Tomography-Assessed Adiposity and Skeletal Muscle among Breast Cancer Patients. JNCI Cancer Spectr. 2022 Oct 12. pii: pkac068. doi: 10.1093/jncics/pkac068. [Epub ahead of print] PubMed PMID: 36222575.


Cancer Therapeutics & Host Response

Ramnaraign BH, Lee JH, Ali A, Rogers SC, Fabregas JC, Thomas RM, Allegra CJ, Sahin I, DeRemer DL, George TJ, Chatzkel JA. Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial. Future Oncol. 2022 Nov 18. doi: 10.2217/fon-2022-0392. Online ahead of print. PubMed PMID: 36399037.

Hong S, Zhao J, Wang S, Wang H, Lee JH, Farhadfar N, McGuirk JP, Savani BN, Shahrukh HK, Stiff P, Khera N, Hahn T, Loren AW, Jaglowski SM, Wood WA, Saber W, Cerny J, Holtan SG, Reynolds JM, Deol A, Jim H, Uberti J, Whalen V, Yi JC, Preussler J, Baker KS, Shaw BE, Devine S, Syrjala K, Majhail NS, Wingard JR, Al-Mansour Z. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplant (HCT) Survivors. Transplant Cell Ther. 2022 Nov 22:S2666-6367(22)01781-X. doi: 10.1016/j.jtct.2022.11.016. Online ahead of print. PubMed PMID: 36427784.

Altshuler E, Mathavan A, Mathavan A, Krekora U, Mathavan M, Hones K, Daily K. Clinical characteristics, prognostic factors, and long-term outcomes associated with epithelial malignancies of the thymus: A 20-year single-institution experience. Cancer Rep (Hoboken). 2022 Nov 12:e1750. doi: 10.1002/cnr2.1750. Online ahead of print. PubMed PMID: 36369906.

Ligon JA, Hayashi M, Ciampa D, Kramer C, Guastella A, Fuchs RJ, Herati AS, Christianson MS, Chen AR. A multidisciplinary pediatric oncofertility team improves fertility preservation and counseling across 7 years. Cancer Rep (Hoboken). 2022 Nov 8:e1753. doi: 10.1002/cnr2.1753. Online ahead of print. PubMed PMID: 36346013.

Fenton GA, Mitchell DA. Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic. Clin Cancer Res. 2022 Nov 16:CCR-22-2257. doi: 10.1158/1078-0432.CCR-22-2257. Online ahead of print. PubMed PMID: 36383184.

Cyr MG, Mhibik M, Qi J, Peng H, Chang J, Gaglione EM, Eik D, Herrick J, Venables T, Novick SJ, Courouble VV, Griffin PR, Wiestner A, Rader C. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia. J Immunother Cancer. 2022 Nov;10(11):e004850. doi: 10.1136/jitc-2022-004850. PubMed PMID: 36442911.

Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D’Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2022 Nov 17. doi: 10.1001/jamaoncol.2022.5370. Online ahead of print. PubMed PMID: 36394838.

Lee D, Gimple RC, Wu X, Prager BC, Qiu Z, Wu Q, Daggubati V, Mariappan A, Gopalakrishnan J, Sarkisian MR, Raleigh DR, Rich JN. Superenhancer-activation of KLHDC8A drives glioma ciliation and hedgehog signaling. J Clin Invest. 2022 Nov 17:e163592. doi: 10.1172/JCI163592. Online ahead of print. PubMed PMID: 36394953.

Trudeau MT, Casciani F, Maggino L, Seykora TF, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Castillo CF, Christein JD, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Salem RR, Wolfgang CL, Zureikat AH, Vollmer CM; Pancreas Fistula Study Group. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy. Ann Surg. 2022 Nov 1;276(5):e527-e535. doi: 10.1097/SLA.0000000000004549. Epub 2020 Nov 12. PubMed PMID: 33201132.

Li JW, Zheng G, Kaye FJ, Wu L. PROTAC therapy as a new targeted therapy for lung cancer. Mol Ther. 2022 Nov 21:S1525-0016(22)00669-4. doi: 10.1016/j.ymthe.2022.11.011. Online ahead of print. PubMed PMID: 36415148.

Yu I, Wu R, Tokumaru Y, Terracina KP, Takabe K. The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer. Cancers (Basel). 2022 Nov 19;14(22):5685. doi: 10.3390/cancers14225685. PubMed PMID: 36428777.

Brooks JT, Solans BP, Lu Y, Kharbanda S, Dvorak CC, Lalefar N, Long S, Gupta AO, Horn B, Lamba JK, Huang L, Apsel-Winger B, Keizer RJ, Savic R, Long-Boyle J. Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation. Pharmaceutics. 2022 Nov 15;14(11):2462. doi: 10.3390/pharmaceutics14112462. PubMed PMID: 36432661.

Schleyer KA, Liu J, Chen Z, Wang Z, Zhang Y, Zuo J, Ybargollin AJ, Guo H, Cui L. A Universal and Modular Scaffold for Heparanase Activatable Probes and Drugs. Bioconjug Chem. 2022 Nov 8. doi: 10.1021/acs.bioconjchem.2c00426. Online ahead of print. PubMed PMID: 36346913.

Lim JE, Sargur Madabushi S, Vishwasrao P, Song JY, Abdelhamid AMH, Ghimire H, Vanishree VL, Lamba JK, Dandapani S, Salhotra A, Lemecha M, Pierini A, Zhao D, Storme G, Holtan S, Aristei C, Schaue D, Al Malki M, Hui SK. Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice. Front Oncol. 2022 Nov 10;12:1045016. doi: 10.3389/fonc.2022.1045016. eCollection 2022. PubMed PMID: 36439420; PubMed Central PMCID: PMC9686437.

MacPherson DS, Hwang D, Sarrett SM, Keinanen O, Rodriguez C, Rader C, Zeglis BM. Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate. Mol Pharm. 2022 Nov 15. doi: 10.1021/acs.molpharmaceut.2c00700. Online ahead of print. PubMed PMID: 36377696.

Erwin N, Serafim MF, He M. Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications. Pharm Res. 2022 Nov 1. doi: 10.1007/s11095-022-03420-w. Online ahead of print. PubMed PMID: 36319886.

Saleh W, Elashry MM, Winn N, Mona M, Katz J, Cha S. A lower prevalence of malignant lymphoma in Sjogren’s syndrome patients: A cross-sectional study. Oral Dis. 2022 Nov 11. doi: 10.1111/odi.14435. Online ahead of print. PubMed PMID: 36369668.

Ellison ST, Duraivel S, Subramaniam V, Hugosson F, Yu B, Lebowitz JJ, Khoshbouei H, Lele TP, Martindale MQ, Angelini TE (CTHR). Cellular micromasonry: biofabrication with single cell precision. Soft Matter. 2022 Nov 23;18(45):8554-8560. doi: 10.1039/d2sm01013e. PubMed PMID: 36350122.

Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O’Brien MM, Rabin KR, Rau RE, Rheingold SR, Wang C, Wood C, Raetz EA, Loh ML, Alexander S, Miller TP. Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2022 Nov;69(11):e29937. doi: 10.1002/pbc.29937. Epub 2022 Sep 9. PubMed PMID: 36083863; PubMed Central PMCID: PMC9529813.

Kelsey TW, Hua CH, Wyatt A, Indelicato D, Wallace WH. A predictive model of the effect of therapeutic radiation on the human ovary. PLoS One. 2022 Nov 18;17(11):e0277052. doi: 10.1371/journal.pone.0277052. eCollection 2022. PubMed PMID: 36399448; PubMed Central PMCID: PMC9674157.

Jaiswal A, Jaiswal A, Williamson EA, Gelfond J, Zheng G, Zhou D, Hromas R. Resistance to the BCL-XL degrader DT2216 in T-cell acute lymphoblastic leukemia is rare and correlates with decreased BCL-XL proteolysis. Cancer Chemother Pharmacol. 2022 Nov 8. doi: 10.1007/s00280-022-04490-8. Online ahead of print. PubMed PMID: 36346454.

McGrath AM, Cook MR, Culp WT, Oblak ML, Oramas A, Bertran J, Tremolada G, Lapsley J, Selmic LE. Hemangiosarcoma of the nasal planum in cats: five cases (2010-2021). J Feline Med Surg. 2022 Nov 9:1098612X221123772. doi: 10.1177/1098612X221123772. Online ahead of print. PubMed PMID: 36350308.

Graff SL, Subbiah IM, Markham MJ, Matt-Amaral LB, Close JL, Griffith KA, Jagsi R. Frequency, Barriers, Outcomes, and Consequences of Reporting Sexual Harassment in Clinical Oncology. JNCI Cancer Spectr. 2022 Nov 23:pkac081. doi: 10.1093/jncics/pkac081. Online ahead of print. PubMed PMID: 36416149.

Ligon JA, Sundby RT, Wedekind Malone MF, Arnaldez FI, Del Rivero J, Wiener L, Srinivasan R, Spencer M, Carbonell A, Lei H, Shern J, Steinberg SM, Figg WD, Peer CJ, Zimmerman S, Moraly J, Xu X, Fox S, Chan K, Barbato MI, Andresson T, Taylor N, Pacak K, Killian JK, Dombi E, Linehan WM, Miettinen M, Piekarz R, Helman LJ, Meltzer P, Widemann B, Glod J. A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-associated Renal Cell Carcinoma. Clin Cancer Res. 2022 Oct 27. pii: CCR-22-2168. doi: 10.1158/1078-0432.CCR-22-2168. [Epub ahead of print] PubMed PMID: 36302175.

Doerr V, Montalvo RN, Nguyen BL, Boeno FP, Sunshine MD, Bindi VE, Fuller DD, Smuder AJ. Effects of Hyperbaric Oxygen Preconditioning on Doxorubicin Cardiorespiratory Toxicity. Antioxidants (Basel). 2022 Oct 20;11(10). pii: 2073. doi: 10.3390/antiox11102073. PubMed PMID: 36290796; PubMed Central PMCID: PMC9598583.

Liang C, Zhang Q, Chen X, Liu J, Tanaka M, Wang S, Lepler SE, Jin Z, Siemann DW, Zeng B, Tang X. Human cancer cells generate spontaneous calcium transients and intercellular waves that modulate tumor growth. Biomaterials. 2022 Oct 5;290:121823. doi: 10.1016/j.biomaterials.2022.121823. [Epub ahead of print] PubMed PMID: 36209577.

Boyiadzis M, Zhang MJ, Chen K, Abdel-Azim H, Abid MB, Aljurf M, Bacher U, Badar T, Badawy SM, Battiwalla M, Bejanyan N, Bhatt VR, Brown VI, Castillo P, Cerny J, Copelan EA, Craddock C, Dholaria B, Perez MAD, Ebens CL, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt GC, Iqbal M, Jamy O, Kharfan-Dabaja MA, Khera N, Lazarus HM, Lin R, Modi D, Nathan S, Nishihori T, Patel SS, Pawarode A, Sharma A, Solh M, Wagner JL, Wang T, Williams KM, Winestone LE, Wirk B, Hourigan CS, Litzow M, Kebriaei P, de Lima M, Page K, Weisdorf DJ. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia. 2022 Oct 30. doi: 10.1038/s41375-022-01738-3. [Epub ahead of print] PubMed PMID: 36310182.

Blinder VS, Garrett-Mayer E, Jacobsen PB, Kozlik MM, Markham MJ, Siegel RD, Kamal AH, Crist STS, Rosenthal J, Chiang AC. Oral Chemotherapy Metric Performance in Quality Oncology Practice Initiative Practices: Updated Trends and Analysis. J Natl Compr Canc Netw. 2022 Oct;20(10):1099-1106.e2. doi: 10.6004/jnccn.2022.7024. PubMed PMID: 36240846.

Roth ME, Parsons SK, Ganz PA, Wagner LI, Hinds PS, Alexander S, Bingen K, Bober SL, Brackett J, Cella D, Henry NL, Indelicato DJ, Johnson RH, Miller TP, Rosenberg SM, Schmitz KH, Thanarajasingam G, Reeve BB, Salsman JM. Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. J Natl Cancer Inst. 2022 Oct 21. pii: djac166. doi: 10.1093/jnci/djac166. [Epub ahead of print] PubMed PMID: 36266760.

Huot JR, Baumfalk D, Resendiz A, Bonetto A, Smuder AJ, Penna F. Targeting mitochondria and oxidative stress in cancer- and chemotherapy-induced muscle wasting. Antioxid Redox Signal. 2022 Oct 31. doi: 10.1089/ars.2022.0149. [Epub ahead of print] PubMed PMID: 36310444.

Gustafson MP, Ligon JA, Bersenev A, McCann CD, Shah NN, Hanley PJ. Emerging frontiers in immuno- and gene therapy for cancer. Cytotherapy. 2022 Oct 21. pii: S1465-3249(22)00827-1. doi: 10.1016/j.jcyt.2022.10.002. [Epub ahead of print] PubMed PMID: 36280438.

Mansouri S, Gogoi H, Patel S, Katikaneni DS, Singh A, Aybar-Torres A, de Lartigue G, Jin L. MPYS Modulates Fatty Acid Metabolism and Immune Tolerance at Homeostasis Independent of Type I IFNs. J Immunol. 2022 Oct 19. pii: ji2200158. doi: 10.4049/jimmunol.2200158. [Epub ahead of print] PubMed PMID: 36261171.

Kanumuri SRR, Mamallapalli J, Nelson R, McCurdy CR, Mathews CA, Xing C, Sharma A. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers. J Ethnopharmacol. 2022 Oct 28;297:115514. doi: 10.1016/j.jep.2022.115514. Epub 2022 Jun 28. PubMed PMID: 35777607.

Morfouace M, Hol MLF, Schoot RA, Slater O, Indelicato DJ, Kolb F, Smeele LE, Merks JHM, Rae C, Maurice-Stam H, Klassen AF, Grootenhuis MA. Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial module. Cancer Med. 2022 Oct 7. doi: 10.1002/cam4.5252. [Epub ahead of print] PubMed PMID: 36208014.

Scarton L, Jo A, Xie Z, O’Neal LJ, Munoz Pena JM, George TJ, Bian J. Examining the relationship between metformin dose and cancer survival: A SEER-Medicare analysis. PLoS One. 2022 Oct 19;17(10):e0275681. doi: 10.1371/journal.pone.0275681. eCollection 2022. PubMed PMID: 36260549; PubMed Central PMCID: PMC9581409.

Coca-Pelaz A, Rodrigo JP, Lopez F, Shah JP, Silver CE, Al Ghuzlan A, Menke-van der Houven van Oordt CW, Smallridge RC, Shaha AR, Angelos P, Mendenhall WM, Piazza C, Olsen KD, Corry J, Tufano RP, Sanabria A, Nuyts S, Nathan CA, Vander Poorten V, Dias FL, Suarez C, Saba NF, de Graaf P, Williams MD, Rinaldo A, Ferlito A. Evaluating new treatments for anaplastic thyroid cancer. Expert Rev Anticancer Ther. 2022 Oct 25. doi: 10.1080/14737140.2022.2139680. [Epub ahead of print] PubMed PMID: 36283091.

Alpert JM, Hampton CN, Raisa A, Markham MJ, Bylund CL. Integrating patient-centeredness into online patient-clinician communication: a qualitative analysis of clinicians’ secure messaging usage. Support Care Cancer. 2022 Oct 19. doi: 10.1007/s00520-022-07408-5. [Epub ahead of print] PubMed PMID: 36260178; PubMed Central PMCID: PMC9580446.

Knewitz D, Charles AM, Thomas RM. Association of Medical Appointment Cancellation Rates on Survival After Esophagectomy for Esophageal Cancer. J Gastrointest Surg. 2022 Oct 26. doi: 10.1007/s11605-022-05491-x. [Epub ahead of print] PubMed PMID: 36289186; PubMed Central PMCID: PMC9607859.

Bilgili A, Tuna IS, Rahman M, Naney TD, Albayram MS. Visualization of the perivenous glymphatic efflux in human brain after laser interstitial thermal therapy. Magn Reson Imaging. 2022 Oct;92:96-99. doi: 10.1016/j.mri.2022.06.013. Epub 2022 Jun 25. PubMed PMID: 35764218.

Melnick K, Miller P, Carmichael E, Wang Y, Tran D, Kresak JL, Ghiaseddin A, Rahman M. Histologic Findings at Time of Repeat Resection Predicts Survival in Patients with Glioblastoma. World Neurosurg. 2022 Oct 4. pii: S1878-8750(22)01405-X. doi: 10.1016/j.wneu.2022.09.128. [Epub ahead of print] PubMed PMID: 36206964.

De Leo AN, Drescher N, Bates JE, Yeung AR. Challenges in the transition to independent radiation oncology practice and targeted interventions for improvement. Tech Innov Patient Support Radiat Oncol. 2022 Sep 29;24:113-117. doi: 10.1016/j.tipsro.2022.09.002. PMID: 36387780; PMCID: PMC9641029.

Hitchcock KE, Drescher NR. New Growth After Planted Seeds, Treat With Rays. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):831-832. doi: 10.1016/j.ijrobp.2022.09.015. Epub 2022 Nov 14. PMID: 36395801.


Mechanisms of Oncogenesis

Li JW, Zheng G, Kaye FJ, Wu L. PROTAC therapy as a new targeted therapy for lung cancer. Mol Ther. 2022 Nov 21:S1525-0016(22)00669-4. doi: 10.1016/j.ymthe.2022.11.011. Online ahead of print. PubMed PMID: 36415148.

Riveros C, Chalfant V, Di Valerio E, Bacchus MW, Forero AM, Klett D, Balaji KC. Glomerular hyperfiltration is a predictor of adverse outcomes following major urologic oncology surgery. Int Urol Nephrol. 2022 Nov 1. doi: 10.1007/s11255-022-03400-4. Online ahead of print. PubMed PMID: 36318406.

Zeng W, Beyene HB, Kuokkanen M, Miao G, Magliano DJ, Umans JG, Franceschini N, Cole SA, Michailidis G, Lee ET, Howard BV, Fiehn O, Curran JE, Blangero J, Meikle PJ, Zhao J. Lipidomic profiling in the Strong Heart Study identified American Indians at risk of chronic kidney disease. Kidney Int. 2022 Nov;102(5):1154-1166. doi: 10.1016/j.kint.2022.06.023. Epub 2022 Jul 16. PubMed PMID: 35853479.

Wei X, Wang X, Zhang Z, Luo Y, Wang Z, Xiong W, Jain PK, Monnier JR, Wang H, Hu TY, Tang C, Albrecht H, Liu C. A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples. Nat Commun. 2022 Nov 11;13(1):6852. doi: 10.1038/s41467-022-34273-x. PubMed PMID: 36369146; PubMed Central PMCID: PMC9651128.

Cyr MG, Mhibik M, Qi J, Peng H, Chang J, Gaglione EM, Eik D, Herrick J, Venables T, Novick SJ, Courouble VV, Griffin PR, Wiestner A, Rader C. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia. J Immunother Cancer. 2022 Nov;10(11):e004850. doi: 10.1136/jitc-2022-004850. PubMed PMID: 36442911.

Yagiz Y, Wang GP, Gu L. Emulsification by vitamin E TPGS or Quillaja extract enhanced absorption of berberine without affecting its metabolism in humans. Food Funct. 2022 Nov 28;13(23):12135-12143. doi: 10.1039/d2fo02288e. PubMed PMID: 36321951.

Nguyen L, Schultz DC, Terzyan SS, Rezaei M, Songb J, Li C, You Y, Hanigan MH. Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase. Bioorg Med Chem. 2022 Nov 1;73:116986. doi: 10.1016/j.bmc.2022.116986. Epub 2022 Aug 27. PubMed PMID: 36208545.

Liang C, Zhang Q, Chen X, Liu J, Tanaka M, Wang S, Lepler SE, Jin Z, Siemann DW, Zeng B, Tang X. Human cancer cells generate spontaneous calcium transients and intercellular waves that modulate tumor growth. Biomaterials. 2022 Oct 5;290:121823. doi: 10.1016/j.biomaterials.2022.121823. [Epub ahead of print] PubMed PMID: 36209577.

Sarwar S, Morozov VM, Purayil H, Daaka Y, Ishov AM. Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer. Cell Death Dis. 2022 Oct 13;13(10):868. doi: 10.1038/s41419-022-05312-8. PubMed PMID: 36229449; PubMed Central PMCID: PMC9561175.

Skoko JJ, Cao J, Gaboriau D, Attar M, Asan A, Hong L, Paulsen CE, Ma H, Liu Y, Wu H, Harkness T, Furdui CM, Manevich Y, Morrison CG, Brown ET, Normolle D, Spies M, Spies MA, Carroll K, Neumann CA. Redox regulation of RAD51 Cys319 and homologous recombination by peroxiredoxin 1. Redox Biol. 2022 Oct;56:102443. doi: 10.1016/j.redox.2022.102443. Epub 2022 Aug 24. PubMed PMID: 36058112; PubMed Central PMCID: PMC9450138.

Zhou W, Yadav GP, Yang X, Qin F, Li C, Jiang QX. Cryo-EM structure-based selection of computed ligand poses enables design of MTA-synergic PRMT5 inhibitors of better potency. Commun Biol. 2022 Oct 3;5(1):1054. doi: 10.1038/s42003-022-03991-9. PubMed PMID: 36192627; PubMed Central PMCID: PMC9530242.

Lampejo AO, Jo M, Murfee WL, Breslin JW. The Microvascular-Lymphatic Interface and Tissue Homeostasis: Critical Questions That Challenge Current Understanding. J Vasc Res. 2022 Oct 31:1-16. doi: 10.1159/000525787. [Epub ahead of print] Review. PubMed PMID: 36315992.

Aduse-Poku L, Gopireddy DR, Hernandez M, Lall C, Divaker J, Falzarano SM, Masood S, Datta S, Zhang W, Jo A, Bian J, Cheng TD. Intraindividual Reliability of Opportunistic Computed Tomography-Assessed Adiposity and Skeletal Muscle among Breast Cancer Patients. JNCI Cancer Spectr. 2022 Oct 12. pii: pkac068. doi: 10.1093/jncics/pkac068. [Epub ahead of print] PubMed PMID: 36222575.